These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29673879)

  • 1. Trimethoprim susceptibility in E. coli community-acquired urinary tract infections in France.
    Duployez C; Robert J; Vachée A;
    Med Mal Infect; 2018 Sep; 48(6):410-413. PubMed ID: 29673879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates.
    Burman WJ; Breese PE; Murray BE; Singh KV; Batal HA; MacKenzie TD; Ogle JW; Wilson ML; Reves RR; Mehler PS
    Am J Med; 2003 Oct; 115(5):358-64. PubMed ID: 14553870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.
    Hillier S; Roberts Z; Dunstan F; Butler C; Howard A; Palmer S
    J Antimicrob Chemother; 2007 Jul; 60(1):92-9. PubMed ID: 17540675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.
    Manges AR; Johnson JR; Foxman B; O'Bryan TT; Fullerton KE; Riley LW
    N Engl J Med; 2001 Oct; 345(14):1007-13. PubMed ID: 11586952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections].
    Junquera S; Loza E; Baquero F
    Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):197-201. PubMed ID: 15826543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
    Rock W; Colodner R; Chazan B; Elias M; Raz R
    Isr Med Assoc J; 2007 Nov; 9(11):803-5. PubMed ID: 18085038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current state of resistance of E. coli to trimethoprim in uncomplicated urinary tract infections in France].
    Mabboux P; Rouveix B
    Prog Urol; 2019 Dec; 29(16):943-946. PubMed ID: 31757712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?
    Mangin D; Toop L; Chambers S; Ikram R; Harris B
    N Z Med J; 2005 Nov; 118(1225):U1726. PubMed ID: 16286940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.
    Minassian MA; Lewis DA; Chattopadhyay D; Bovill B; Duckworth GJ; Williams JD
    Int J Antimicrob Agents; 1998 Apr; 10(1):39-47. PubMed ID: 9624542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of guidelines for the diagnosis of urinary tract infection on trimethoprim susceptibility of Escherichia coli.
    Batchelor BI; Crook DW; Jones T; Bowler IC
    J Antimicrob Chemother; 2002 Jan; 49(1):223-4. PubMed ID: 11751797
    [No Abstract]   [Full Text] [Related]  

  • 11. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.
    Nguyen HT; Hurwitz RS; Defoor WR; Minevich E; McAdam AJ; Mortensen JE; Novak-Weekley SM; Minnillo BJ; Elder JS
    J Urol; 2010 Jul; 184(1):305-10. PubMed ID: 20488468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of urinary tract infections in children with trimethoprim-sulfamethoxypyridazine].
    Rodríguez W; Delucchi C; Bidegain MA; Rodríguez MS; Gleisner A; Figueroa S
    Rev Chil Pediatr; 1983; 54(6):402-6. PubMed ID: 6379766
    [No Abstract]   [Full Text] [Related]  

  • 13. Trimethoprim prescription and subsequent resistance in childhood urinary infection: multilevel modelling analysis.
    Duffy MA; Hernandez-Santiago V; Orange G; Davey PG; Guthrie B
    Br J Gen Pract; 2013 Apr; 63(609):e238-43. PubMed ID: 23540479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current state of antibiotic resistance of pathogens causing community-acquired urinary tract infections in Russia, Belarus and Kazakhstan: results of the international multicenter study Darmis-2018].
    Palagin IS; Sukhorukova MV; Dekhnich AV; Edelstein MV; Perepanova TS; Kozlov RS
    Urologiia; 2020 Mar; (1):19-31. PubMed ID: 32190999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
    Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
    BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories.
    Richards DA; Toop LJ; Chambers ST; Sutherland MG; Harris BH; Ikram RB; Jones MR; McGeoch GR; Peddie B
    N Z Med J; 2002 Jan; 115(1146):12-4. PubMed ID: 11936326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of levofloxacin susceptibility against strains isolated from lower urinary tract infections in the community].
    Weber P; Dib C; Durand C; Moniot-Ville N
    Pathol Biol (Paris); 2005 Mar; 53(2):125-8. PubMed ID: 15708658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
    Kahlmeter G; Poulsen HO
    Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing in vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.